Forty-three years after it was founded, with billions of dollars invested, the global biotech industry is still not positioned as a mature low-risk sector for the international investor com-munity. Despite the clear commercial success of a number of leading companies and overall growth of the industry’s rev-enues, most biotech companies are not profi table and many fail to overcome the formidable barrier constituted by the high cost of the sector’s research and development.
However, over the last four years, visible signs of change have appeared, which could be harbingers of an approaching turning point in this trend.This article analyzes the historic background of the biotech in-dustry’s business models and corporate structures, as well as their impact on the industry’s fi nancial framework.
It examines recent changes implemented by the sector’s main actors-in-cluding young startups, venture capital funds and big pharma companies-to mitigate fi nancial risk associated with develop-ment of new biotechnology products.Finally, it discusses the challenges and opportunities that these tendencies entail for Cuban biotechnology development and proposes adoption of business policies more tolerant of the fi nancial risk inherent in this sector, as a condition for at-tracting venture capital. KEYWORDS Biotechnology, fund raising, risk management, entrepreneurship, Cuba.
Mouse anti Human IgG1 |
10R-I110a |
Fitzgerald |
1 ml |
EUR 1990 |
|
Description: Mouse anti Human IgG1 antibody |
Mouse anti Human IgG1 |
10R-I127a |
Fitzgerald |
1 mg |
EUR 429 |
|
Description: Mouse anti Human IgG1 antibody |
MOUSE ANTI HUMAN IgG1 |
MBS211708-05mg |
MyBiosource |
0.5mg |
EUR 585 |
MOUSE ANTI HUMAN IgG1 |
MBS211708-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2450 |
Mouse anti Human IgG1 |
MBS530111-1mg |
MyBiosource |
1mg |
EUR 620 |
Mouse anti Human IgG1 |
MBS530111-5x1mg |
MyBiosource |
5x1mg |
EUR 2640 |
Mouse anti Human IgG1 |
MBS531698-1mg |
MyBiosource |
1mg |
EUR 790 |
Mouse anti Human IgG1 |
MBS531698-5x1mg |
MyBiosource |
5x1mg |
EUR 3405 |
Mouse anti Human IgG1 |
MBS530772-05mg |
MyBiosource |
0.5mg |
EUR 1160 |
Mouse anti Human IgG1 |
MBS530772-5x05mg |
MyBiosource |
5x0.5mg |
EUR 5065 |
Mouse anti Human IgG1 (HRP) |
43-1003 |
Fitzgerald |
1 ml |
EUR 263 |
|
Description: Mouse Anti-Human IgG1, Fc-HRP |
Mouse Anti Human IgG1 (HRP) |
MBS5311067-1mL |
MyBiosource |
1mL |
EUR 455 |
Mouse Anti Human IgG1 (HRP) |
MBS5311067-5x1mL |
MyBiosource |
5x1mL |
EUR 1905 |
Anti-HA [CR6261], Human IgG1 |
MBS488950-02mg |
MyBiosource |
0.2mg |
EUR 520 |
Anti-HA [CR6261], Human IgG1 |
MBS488950-5x02mg |
MyBiosource |
5x0.2mg |
EUR 2160 |
Anti-MAGEA3 [21B4], Human IgG1 |
MBS488971-02mg |
MyBiosource |
0.2mg |
EUR 520 |
Anti-MAGEA3 [21B4], Human IgG1 |
MBS488971-5x02mg |
MyBiosource |
5x0.2mg |
EUR 2160 |
anti-RhoD human antigen IgG1 |
131-A |
Virogen |
1 MG |
EUR 850 |
anti-RhoD human antigen IgG1 |
131-A-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: anti-RhoD human antigen IgG1 |
anti-RhoD human antigen IgG1 |
131-A-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: anti-RhoD human antigen IgG1 |
anti-RhoD human antigen IgG1 |
131-A-100ugvial |
Virogen |
100ug/vial |
EUR 150 |
|
Description: anti-RhoD human antigen IgG1 |
Swine anti Human IgG1 IgG2 IgG3 IgG4 |
MBS571919-4x05mL |
MyBiosource |
4x0.5mL |
EUR 720 |
Anti-HA [310-18A3], Human IgG1 |
MBS488973-02mg |
MyBiosource |
0.2mg |
EUR 520 |
Anti-HA [310-18A3], Human IgG1 |
MBS488973-5x02mg |
MyBiosource |
5x0.2mg |
EUR 2160 |
Anti-PD-L1 [332M7], Human IgG1 |
MBS488961-02mg |
MyBiosource |
0.2mg |
EUR 520 |
Anti-PD-L1 [332M7], Human IgG1 |
MBS488961-5x02mg |
MyBiosource |
5x0.2mg |
EUR 2160 |
HRP*Monoclonal Mouse Anti- Human IgG1 |
C030248-10ml |
Unibiotest |
10ml |
EUR 3162 |
HRP*Monoclonal Mouse Anti- Human IgG1 |
C030248-1ml |
Unibiotest |
1ml |
EUR 525.6 |
FITC*Monoclonal Mouse Anti- Human IgG1 |
C030648-1ml |
Unibiotest |
1ml |
EUR 525.6 |
FITC*Monoclonal Mouse Anti- Human IgG1 |
C030648-10ml |
Unibiotest |
10ml |
EUR 3162 |
Mouse anti Human IgG1 Monoclonal Antibody |
MBS460955-01mg |
MyBiosource |
0.1mg |
EUR 320 |
Mouse anti Human IgG1 Monoclonal Antibody |
MBS460955-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1390 |
BIOTIN*Monoclonal Mouse Anti- Human IgG1 |
C030848-10ml |
Unibiotest |
10ml |
EUR 2148 |
BIOTIN*Monoclonal Mouse Anti- Human IgG1 |
C030848-1ml |
Unibiotest |
1ml |
EUR 424.8 |
Human IC IgG1/IgG1 antibodies combination |
ICIGG1FPE-50T |
ImmunoStep |
50 test |
EUR 165 |
Anti-OX40L (Oxelumab), Human IgG1 Antibody |
A1088-200 |
Biovision |
each |
EUR 874.8 |
Anti-EGFR (Matuzumab), Human IgG1 Antibody |
A1090-200 |
Biovision |
each |
EUR 874.8 |
Anti-RSV (Felvizumab), Human IgG1 Antibody |
A1446-200 |
Biovision |
each |
EUR 874.8 |
Anti-CD20 (Ofatumumab), Human IgG1 Antibody |
A2172-100 |
Biovision |
100 µg |
EUR 564 |
Anti-CD11a (Efalizumab), Human IgG1 Antibody |
A1089-200 |
Biovision |
each |
EUR 874.8 |
Anti-CD40L (Ruplizumab), Human IgG1 Antibody |
A1094-200 |
Biovision |
each |
EUR 874.8 |
Anti-CD22 (Epratuzumab), Human IgG1 Antibody |
A1445-200 |
Biovision |
each |
EUR 933.6 |
Anti-CD38 (Daratumumab), Human IgG1 Antibody |
A2151-100 |
Biovision |
100 µg |
EUR 612 |
Anti-PCSK9 (Alirocumab), Human IgG1 Antibody |
A2153-100 |
Biovision |
100 µg |
EUR 612 |
Anti-TNSF13B (Belimumab), Human IgG1 Antibody |
A2170-100 |
Biovision |
100 µg |
EUR 612 |
Anti-VEGFR2 (Ramucirumab), Human IgG1 Antibody |
A2139-100 |
Biovision |
100 µg |
EUR 612 |
Anti-Beta-galactosidase, Human IgG1 Antibody |
A1104-200 |
Biovision |
each |
EUR 933.6 |
Anti-TRP-1, gp75 [TA99], Human IgG1 |
MBS488876-02mg |
MyBiosource |
0.2mg |
EUR 520 |
Anti-TRP-1, gp75 [TA99], Human IgG1 |
MBS488876-5x02mg |
MyBiosource |
5x0.2mg |
EUR 2160 |
Anti-V5 epitope tag, Human IgG1 Antibody |
A1103-200 |
Biovision |
each |
EUR 933.6 |
Human IgG1 Anti-Zika Virus NS1 Antibody |
MAB12122-100 |
The Native Antigen Company |
0.1 |
EUR 459.27 |
|
Description: Human IgG monoclonal antibody specific for Zika virus NS1 (clone B4) |
Human IgG1 Anti-Zika Virus NS1 Antibody |
MAB12122-250 |
The Native Antigen Company |
0.25 |
EUR 890.47 |
|
Description: Human IgG monoclonal antibody specific for Zika virus NS1 (clone B4) |
Human IgG1 Anti-Zika Virus NS1 Antibody |
MAB12122-500 |
The Native Antigen Company |
0.5 |
EUR 1222.17 |
|
Description: Human IgG monoclonal antibody specific for Zika virus NS1 (clone B4) |
Mouse anti Human IgG1 (Fc subclass specific) |
MBS571031-05mg |
MyBiosource |
0.5mg |
EUR 590 |
Mouse anti Human IgG1 (Fc subclass specific) |
MBS571031-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2510 |
Mouse anti Human IgG1 (Fc subclass specific) |
MBS571084-02mg |
MyBiosource |
0.2mg |
EUR 715 |
Mouse anti Human IgG1 (Fc subclass specific) |
MBS571084-5x02mg |
MyBiosource |
5x0.2mg |
EUR 3080 |
Human IgG1 Antibody |
R20187-100UG |
NSJ Bioreagents |
100ug |
EUR 347.65 |
|
Description: This recombinant Human IgG1 antibody reacts to the heavy chain of hIgG1. No cross reactivity with IgG2, IgG3, IgG4, IgM, IgA, IgD, IgE, mouse/rat/goat IgG. |
Human IgG1 Antibody |
R20187BTN-50UG |
NSJ Bioreagents |
50ug |
EUR 347.65 |
|
Description: This recombinant Human IgG1 antibody reacts to the heavy chain of human IgG1. No cross reactivity with human IgG2, IgG3, IgG4, IgM, IgA, IgD, IgE, mouse/rat/goat IgG. |
Human IgG1 Antibody |
R20187SAF-250UG |
NSJ Bioreagents |
250ug |
EUR 832.15 |
|
Description: This recombinant Human IgG1 antibody reacts to the heavy chain of hIgG1. No cross reactivity with IgG2, IgG3, IgG4, IgM, IgA, IgD, IgE, mouse/rat/goat IgG. |
Anti-PD-L1 (Avelumab), Human IgG1 Antibody |
A2152-100 |
Biovision |
100 µg |
EUR 612 |
Anti-CD52 (Campath-1H), Human IgG1 Antibody |
A1105-200 |
Biovision |
each |
EUR 933.6 |
Anti-TNF-α (Golimumab), Human IgG1 Antibody |
A2141-100 |
Biovision |
100 µg |
EUR 612 |
Anti-PD-L1 (Durvalumab), Human IgG1 Antibody |
A2109-100 |
Biovision |
100 µg |
EUR 612 |
Anti-IL-1β (Canakinumab), Human IgG1 Antibody |
A2144-100 |
Biovision |
100 µg |
EUR 564 |
Anti-IL-23α (Guselkumab), Human IgG1 Antibody |
A2147-100 |
Biovision |
100 µg |
EUR 612 |
Anti-TNF alpha (Infliximab), Human IgG1 Antibody |
A1097-200 |
Biovision |
each |
EUR 933.6 |
Anti-IL-12β (Ustekinumab), Human IgG1 Antibody |
A2137-100 |
Biovision |
100 µg |
EUR 612 |
Anti-IL-17α (Secukinumab), Human IgG1 Antibody |
A2154-100 |
Biovision |
100 µg |
EUR 612 |
Anti-CD80 (Galiximab), Human IgG1, lambda Antibody |
A2011-200 |
Biovision |
200 µg |
EUR 818.4 |
Anti-IGF-1R (Teprotumumab), Human IgG1 Antibody |
A2160-100 |
Biovision |
100 µg |
EUR 612 |
Monoclonal Anti-IFNγ Antibody, Human IgG1 (8C5F8) |
IFN-M412-100ug |
ACROBIOSYSTEMS |
100ug |
EUR 327 |
Description: Interferon-gamma (IFN-γ/IFNG) is a dimerized soluble cytokine that is the only member of the type II class of interferon. This interferon was originally called macrophage-activating factor, a term now used to describe a larger family of proteins to which IFN-γ belongs. IFN-gamma has been used in a wide variety of clinical indications. Interferon-gamma (IFNgamma) is a central regulator of the immune response and signals via the Janus Activated Kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) pathway. Interferon gamma has broader roles in activation of innate and adaptive immune responses to viruses and tumors, in part through upregulating transcription of genes involved in cell cycle regulation, apoptosis, and antigen processing/presentation. Despite this, rodent and human trophoblast cells show dampened responses to IFNG that reflect the resistance of these cells to IFNG-mediated activation of major histocompatibility complex (MHC) class II transplantation antigen expression. |
Monoclonal Anti-IFNγ Antibody, Human IgG1 (8C5F8) |
IFN-M412-1mg |
ACROBIOSYSTEMS |
1mg |
EUR 2398 |
Description: Interferon-gamma (IFN-γ/IFNG) is a dimerized soluble cytokine that is the only member of the type II class of interferon. This interferon was originally called macrophage-activating factor, a term now used to describe a larger family of proteins to which IFN-γ belongs. IFN-gamma has been used in a wide variety of clinical indications. Interferon-gamma (IFNgamma) is a central regulator of the immune response and signals via the Janus Activated Kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) pathway. Interferon gamma has broader roles in activation of innate and adaptive immune responses to viruses and tumors, in part through upregulating transcription of genes involved in cell cycle regulation, apoptosis, and antigen processing/presentation. Despite this, rodent and human trophoblast cells show dampened responses to IFNG that reflect the resistance of these cells to IFNG-mediated activation of major histocompatibility complex (MHC) class II transplantation antigen expression. |
Monoclonal Anti-IFNγ Antibody, Human IgG1 (8C5F8) |
IFN-M412 |
ACROBIOSYSTEMS |
100ug |
EUR 2354 |
|
Description: IFNγ is secreted by innate-like lymphocytes, including group 1 innate lymphoid cells (ILC1s), and by adaptive lymphocytes, including T helper 1 (TH1) cells and cytotoxic T lymphocytes (CTLs), in response to cytokine and antigen stimulation. It plays important roles in tissue homeostasis, immune and inflammatory responses and tumour immunosurveillance. Anti-IFNγ antibody, is a monoclonal antibody used to detected IFNγ, which is a recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with Human IFN-gamma protein. |
Anti-CD41 [7E3 (Abciximab)], Human IgG1, Kappa |
MBS488496-02mg |
MyBiosource |
0.2mg |
EUR 520 |
Anti-CD41 [7E3 (Abciximab)], Human IgG1, Kappa |
MBS488496-5x02mg |
MyBiosource |
5x0.2mg |
EUR 2160 |
Anti-Flavivirus group antigen, Human IgG1 Antibody |
A1102-200 |
Biovision |
each |
EUR 933.6 |
Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H4) |
IFN-M411-100ug |
ACROBIOSYSTEMS |
100ug |
EUR 327 |
Description: Interferon-gamma (IFN-γ/IFNG) is a dimerized soluble cytokine that is the only member of the type II class of interferon. This interferon was originally called macrophage-activating factor, a term now used to describe a larger family of proteins to which IFN-γ belongs. IFN-gamma has been used in a wide variety of clinical indications. Interferon-gamma (IFNgamma) is a central regulator of the immune response and signals via the Janus Activated Kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) pathway. Interferon gamma has broader roles in activation of innate and adaptive immune responses to viruses and tumors, in part through upregulating transcription of genes involved in cell cycle regulation, apoptosis, and antigen processing/presentation. Despite this, rodent and human trophoblast cells show dampened responses to IFNG that reflect the resistance of these cells to IFNG-mediated activation of major histocompatibility complex (MHC) class II transplantation antigen expression. |
Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H4) |
IFN-M411-1mg |
ACROBIOSYSTEMS |
1mg |
EUR 2398 |
Description: Interferon-gamma (IFN-γ/IFNG) is a dimerized soluble cytokine that is the only member of the type II class of interferon. This interferon was originally called macrophage-activating factor, a term now used to describe a larger family of proteins to which IFN-γ belongs. IFN-gamma has been used in a wide variety of clinical indications. Interferon-gamma (IFNgamma) is a central regulator of the immune response and signals via the Janus Activated Kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) pathway. Interferon gamma has broader roles in activation of innate and adaptive immune responses to viruses and tumors, in part through upregulating transcription of genes involved in cell cycle regulation, apoptosis, and antigen processing/presentation. Despite this, rodent and human trophoblast cells show dampened responses to IFNG that reflect the resistance of these cells to IFNG-mediated activation of major histocompatibility complex (MHC) class II transplantation antigen expression. |
Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H6) |
IFN-M414-100ug |
ACROBIOSYSTEMS |
100ug |
EUR 327 |
Description: Interferon-gamma (IFN-γ/IFNG) is a dimerized soluble cytokine that is the only member of the type II class of interferon. This interferon was originally called macrophage-activating factor, a term now used to describe a larger family of proteins to which IFN-γ belongs. IFN-gamma has been used in a wide variety of clinical indications. Interferon-gamma (IFNgamma) is a central regulator of the immune response and signals via the Janus Activated Kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) pathway. Interferon gamma has broader roles in activation of innate and adaptive immune responses to viruses and tumors, in part through upregulating transcription of genes involved in cell cycle regulation, apoptosis, and antigen processing/presentation. Despite this, rodent and human trophoblast cells show dampened responses to IFNG that reflect the resistance of these cells to IFNG-mediated activation of major histocompatibility complex (MHC) class II transplantation antigen expression. |
Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H6) |
IFN-M414-1mg |
ACROBIOSYSTEMS |
1mg |
EUR 2398 |
Description: Interferon-gamma (IFN-γ/IFNG) is a dimerized soluble cytokine that is the only member of the type II class of interferon. This interferon was originally called macrophage-activating factor, a term now used to describe a larger family of proteins to which IFN-γ belongs. IFN-gamma has been used in a wide variety of clinical indications. Interferon-gamma (IFNgamma) is a central regulator of the immune response and signals via the Janus Activated Kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) pathway. Interferon gamma has broader roles in activation of innate and adaptive immune responses to viruses and tumors, in part through upregulating transcription of genes involved in cell cycle regulation, apoptosis, and antigen processing/presentation. Despite this, rodent and human trophoblast cells show dampened responses to IFNG that reflect the resistance of these cells to IFNG-mediated activation of major histocompatibility complex (MHC) class II transplantation antigen expression. |
Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H4) |
IFN-M411 |
ACROBIOSYSTEMS |
100ug |
EUR 2354 |
|
Description: IFNγ is secreted by innate-like lymphocytes, including group 1 innate lymphoid cells (ILC1s), and by adaptive lymphocytes, including T helper 1 (TH1) cells and cytotoxic T lymphocytes (CTLs), in response to cytokine and antigen stimulation. It plays important roles in tissue homeostasis, immune and inflammatory responses and tumour immunosurveillance. Anti-IFNγ antibody, is a monoclonal antibody used to detected IFNγ, which is a recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with Human IFN-gamma protein. |
Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H6) |
IFN-M414 |
ACROBIOSYSTEMS |
100ug |
EUR 2354 |
|
Description: IFNγ is secreted by innate-like lymphocytes, including group 1 innate lymphoid cells (ILC1s), and by adaptive lymphocytes, including T helper 1 (TH1) cells and cytotoxic T lymphocytes (CTLs), in response to cytokine and antigen stimulation. It plays important roles in tissue homeostasis, immune and inflammatory responses and tumour immunosurveillance. Anti-IFNγ antibody, is a monoclonal antibody used to detected IFNγ, which is a recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with Human IFN-gamma protein. |
Human IgG1 |
31R-1087 |
Fitzgerald |
1 mg |
EUR 230 |
|
Description: Purified native Human IgG1 protein |
Anti-CCR4 (Mogamulizumab), Human IgG1, kappa Antibody |
A2005-200 |
Biovision |
200 µg |
EUR 818.4 |
Goat Anti-Mouse IgG1, Human ads-AP |
MBS674451-1mL |
MyBiosource |
1mL |
EUR 260 |
Goat Anti-Mouse IgG1, Human ads-AP |
MBS674451-5x1mL |
MyBiosource |
5x1mL |
EUR 1010 |
Goat Anti-Mouse IgG1, Human ads-PE |
MBS674455-05mg |
MyBiosource |
0.5mg |
EUR 495 |
Goat Anti-Mouse IgG1, Human ads-PE |
MBS674455-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2070 |
Goat Anti-Mouse IgG1, Human ads-PE |
MBS674456-025mg |
MyBiosource |
0.25mg |
EUR 320 |
Goat Anti-Mouse IgG1, Human ads-PE |
MBS674456-5x025mg |
MyBiosource |
5x0.25mg |
EUR 1295 |
Goat Anti-Mouse IgG1, Human ads-HRP |
LF-SA8005H |
Abfrontier |
1.0 ml |
Ask for price |
Description: Goat polyclonal to mouse IgG1 |
Goat Anti-Mouse IgG1, Human ads-HRP |
MBS674452-1mL |
MyBiosource |
1mL |
EUR 245 |
Goat Anti-Mouse IgG1, Human ads-HRP |
MBS674452-5x1mL |
MyBiosource |
5x1mL |
EUR 945 |
Goat Anti-Mouse IgG1, Human ads-APC |
MBS674457-05mg |
MyBiosource |
0.5mg |
EUR 580 |
Goat Anti-Mouse IgG1, Human ads-APC |
MBS674457-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2470 |
Goat Anti-Mouse IgG1, Human ads-APC |
MBS674458-025mg |
MyBiosource |
0.25mg |
EUR 370 |
Goat Anti-Mouse IgG1, Human ads-APC |
MBS674458-5x025mg |
MyBiosource |
5x0.25mg |
EUR 1520 |
Goat Anti-Mouse IgG1, Human ads-CY5 |
MBS674459-1mg |
MyBiosource |
1mg |
EUR 465 |
Goat Anti-Mouse IgG1, Human ads-CY5 |
MBS674459-5x1mg |
MyBiosource |
5x1mg |
EUR 1935 |
Recombinant Anti-Taq Monoclonal Antibody, Human IgG1 |
MBS430255-01mg |
MyBiosource |
0.1mg |
EUR 185 |
Recombinant Anti-Taq Monoclonal Antibody, Human IgG1 |
MBS430255-1mg |
MyBiosource |
1mg |
EUR 875 |
Recombinant Anti-Taq Monoclonal Antibody, Human IgG1 |
MBS430255-5x1mg |
MyBiosource |
5x1mg |
EUR 3780 |
Goat Anti-Mouse IgG1, Human ads-UNLB |
MBS674448-1mg |
MyBiosource |
1mg |
EUR 290 |
Goat Anti-Mouse IgG1, Human ads-UNLB |
MBS674448-5x1mg |
MyBiosource |
5x1mg |
EUR 1155 |
Goat Anti-Mouse IgG1, Human ads-FITC |
MBS674449-1mg |
MyBiosource |
1mg |
EUR 310 |
Goat Anti-Mouse IgG1, Human ads-FITC |
MBS674449-5x1mg |
MyBiosource |
5x1mg |
EUR 1240 |
Goat Anti-Mouse IgG1, Human ads-TXRD |
MBS674453-1mg |
MyBiosource |
1mg |
EUR 320 |
Goat Anti-Mouse IgG1, Human ads-TXRD |
MBS674453-5x1mg |
MyBiosource |
5x1mg |
EUR 1295 |
Goat Anti-Mouse IgG1, Human ads-BIOT |
MBS674454-1mg |
MyBiosource |
1mg |
EUR 315 |
Goat Anti-Mouse IgG1, Human ads-BIOT |
MBS674454-5x1mg |
MyBiosource |
5x1mg |
EUR 1275 |
Goat Anti-Mouse IgG1, Human ads-TRITC |
MBS674450-1mg |
MyBiosource |
1mg |
EUR 310 |
Goat Anti-Mouse IgG1, Human ads-TRITC |
MBS674450-5x1mg |
MyBiosource |
5x1mg |
EUR 1255 |
Anti-Carcinoembryonic antigen (Arcitumomab), Human IgG1 Antibody |
A1096-200 |
Biovision |
each |
EUR 874.8 |
Anti-Human IgG1:HRP |
IM151 |
Cygnus Technologies |
1 ml |
EUR 386.4 |
|
Description: Anti-Human IgG1:HRP by Cygnus Technologies is available in Europe via Gentaur. |
Anti-human IgG1 antibody |
STJ15100186 |
St John's Laboratory |
250 µg |
EUR 403.2 |
Description: This monoclonal antibody enables sensitive and specific detection of human IgG1 in e.g. antigen-specific ELISA. |
Anti-human IgG1 antibody |
STJ15100187 |
St John's Laboratory |
250 µg |
EUR 440.4 |
Description: This monoclonal antibody enables sensitive and specific detection of human IgG1 in e.g. antigen-specific ELISA. |
Anti-Human IgG1 Antibody |
K03018R01A04C-100ug |
Absea Biotechnology |
100 ug |
EUR 320 |
|
Description: Monoclonal Antibody |
Anti-Human IgG1 Antibody |
K03018R01A04C-1mg |
Absea Biotechnology |
1 mg |
EUR 1600 |
|
Description: Monoclonal Antibody |
Anti-Human IgG1 Antibody |
K03018R01A04C-50ug |
Absea Biotechnology |
50 ug |
EUR 224 |
|
Description: Monoclonal Antibody |
Anti-Human IgG1 Antibody |
K16105M01D05C-100ug |
Absea Biotechnology |
100 ug |
EUR 280 |
|
Description: Monoclonal Antibody |
Anti-Human IgG1 Antibody |
K16105M01D05C-1mg |
Absea Biotechnology |
1 mg |
EUR 1400 |
|
Description: Monoclonal Antibody |
Anti-Human IgG1 Antibody |
K16105M01D05C-50ug |
Absea Biotechnology |
50 ug |
EUR 196 |
|
Description: Monoclonal Antibody |
Anti-Human IgG1 Antibody |
MBS4158889-01mg |
MyBiosource |
0.1mg |
EUR 605 |
Anti-Human IgG1 Antibody |
MBS4158889-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2475 |
Anti-IL-2R alpha (Daclizumab), Human IgG1 Antibody |
A1099-200 |
Biovision |
each |
EUR 874.8 |
Anti-EGFR [2F8 (Zalutumumab; HuMax-EGFR)], Human IgG1 |
MBS488934-02mg |
MyBiosource |
0.2mg |
EUR 520 |
Anti-EGFR [2F8 (Zalutumumab; HuMax-EGFR)], Human IgG1 |
MBS488934-5x02mg |
MyBiosource |
5x0.2mg |
EUR 2160 |
Anti-IL-6 receptor (Tocilizumab), Human IgG1 Antibody |
A1447-200 |
Biovision |
each |
EUR 933.6 |
Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (13B8) |
TNA-AM493 |
ACROBIOSYSTEMS |
1mg |
EUR 321 |
|
Description: Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimers disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated. |
Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (16H5) |
TNA-AM494 |
ACROBIOSYSTEMS |
100ug |
EUR 2140 |
|
Description: Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimers disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated. |
Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (13B8) |
TNA-AM493-100ug |
ACROBIOSYSTEMS |
100ug |
EUR 327 |
Description: Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimer's disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated. |
Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (13B8) |
TNA-AM493-1mg |
ACROBIOSYSTEMS |
1mg |
EUR 2180 |
Description: Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimer's disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated. |
Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (16H5) |
TNA-AM494-100ug |
ACROBIOSYSTEMS |
100ug |
EUR 327 |
Description: Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimer's disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated. |
Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (16H5) |
TNA-AM494-1mg |
ACROBIOSYSTEMS |
1mg |
EUR 2180 |
Description: Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimer's disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated. |
Anti-Nectin-4 (Enfortumab Vedotin), Human IgG1 Antibody |
A2176-100 |
Biovision |
100 µg |
EUR 612 |
Monoclonal Anti-Monkeypox-H3L Antibody, Human IgG1 (1C5) |
H3L-M611 |
ACROBIOSYSTEMS |
1mg |
EUR 374.5 |
|
Description: Monkeypox is a rare zoonosis caused by monkeypox virus, which has become the most serious orthpoxvirus and consists of complex double stranded DNA. The cases are mostly in central and western Africa. The pathogenesis of monkeypox is that the virus invades the body from respiratory mucosa , multiplies in lymphocytes, and incurs into blood producing transient venereal toxemia. after the virus multiplies in cells, the cells can invade the blood and propagate to the skin of the whole body, causing lesions. E8L can Binds to chondroitin sulfate on the cell surface to provide virion attachment to target cell. |
Goat Anti-Mouse IgG1, Human ads-APC/CY7 |
MBS674460-025mg |
MyBiosource |
0.25mg |
EUR 385 |
Goat Anti-Mouse IgG1, Human ads-APC/CY7 |
MBS674460-5x025mg |
MyBiosource |
5x0.25mg |
EUR 1575 |
Monoclonal Anti-Monkeypox-L1R Antibody, Human IgG1 (10D8) |
L1R-M663-100ug |
ACROBIOSYSTEMS |
100ug |
EUR 381.5 |
Description: Monkeypox is a rare zoonosis caused by monkeypox virus, which has become the most serious orthpoxvirus and consists of complex double stranded DNA. The cases are mostly in central and western Africa. The pathogenesis of monkeypox is that the virus invades the body from respiratory mucosa, multiplies in lymphocytes, and incurs into blood producing transient venereal toxemia. after the virus multiplies in cells, the cells can invade the blood and propagate to the skin of the whole body, causing lesions. |
Monoclonal Anti-Monkeypox-L1R Antibody, Human IgG1 (10D8) |
L1R-M663-1mg |
ACROBIOSYSTEMS |
1mg |
EUR 2539.7 |
Description: Monkeypox is a rare zoonosis caused by monkeypox virus, which has become the most serious orthpoxvirus and consists of complex double stranded DNA. The cases are mostly in central and western Africa. The pathogenesis of monkeypox is that the virus invades the body from respiratory mucosa, multiplies in lymphocytes, and incurs into blood producing transient venereal toxemia. after the virus multiplies in cells, the cells can invade the blood and propagate to the skin of the whole body, causing lesions. |
Monoclonal Anti-Monkeypox-L1R Antibody, Human IgG1 (10D8) |
L1R-M663 |
ACROBIOSYSTEMS |
100ug |
EUR 2493.1 |
|
Description: Monkeypox is a rare zoonosis caused by monkeypox virus, which has become the most serious orthpoxvirus and consists of complex double stranded DNA. The cases are mostly in central and western Africa. The pathogenesis of monkeypox is that the virus invades the body from respiratory mucosa, multiplies in lymphocytes, and incurs into blood producing transient venereal toxemia. after the virus multiplies in cells, the cells can invade the blood and propagate to the skin of the whole body, causing lesions. |
Human IgG1 Anti-Flavivirus Envelope Protein Antibody (4G2) |
MAB12268-100 |
The Native Antigen Company |
0.1 |
EUR 290.87 |
|
Description: Human IgG1 monoclonal antibody specific for flavivirus envelope protein (clone 4G2) |
Human IgG1 Anti-Flavivirus Envelope Protein Antibody (4G2) |
MAB12268-500 |
The Native Antigen Company |
0.5 |
EUR 1236.2 |
|
Description: Human IgG1 monoclonal antibody specific for flavivirus envelope protein (clone 4G2) |
Human IgG1-FITC |
MBS666781-01mg |
MyBiosource |
0.1mg |
EUR 415 |
Human IgG1-FITC |
MBS666781-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1710 |
Mouse Anti Human Igg1 (Fc) (Ch2 Domain) Monoclonal Antibody |
CABT-48866MH |
Creative Diagnostics |
0.2 mg |
EUR 920.4 |
Human IgG1 protein |
31-AI17 |
Fitzgerald |
1 mg |
EUR 102 |
|
Description: Purified Human IgG1 protein |
human IgG1 control |
E4A11C03 |
EnoGene |
50ug |
EUR 255 |
Description: Available in various conjugation types. |
Human IgG1 Control |
TP1357-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Human IgG1 Control |
Human IgG1 Control |
TP1357-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Human IgG1 Control |
Human IgG1 Control |
TP1357-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Human IgG1 Control |
Human IgG1 Control |
TP1357-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Human IgG1 Control |
Human IgG1 Control |
TP1357-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Human IgG1 Control |
human IgG1 control |
E4A11D03 |
EnoGene |
50ug |
EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Human IgG1 Control |
MBS5763617-1mg |
MyBiosource |
1mg |
EUR 210 |
Human IgG1 Control |
MBS5763617-5mg |
MyBiosource |
5mg |
EUR 445 |
Human IgG1 Control |
MBS5763617-5x5mg |
MyBiosource |
5x5mg |
EUR 1850 |
Purified human IgG1 |
E16FHCU001-500U |
EnoGene |
0.5 mg |
EUR 433.33 |
Description: Available in various conjugation types. |
Human IgG1-Biotin |
MBS666779-01mg |
MyBiosource |
0.1mg |
EUR 415 |
Human IgG1-Biotin |
MBS666779-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1710 |
Anti-IL-2R alpha (CD25) (Basiliximab), Human IgG1 Antibody |
A1098-200 |
Biovision |
each |
EUR 874.8 |
Monoclonal Anti-RSV-F0 broadly Antibody, Human IgG1 (3B4) |
RSV-M649 |
ACROBIOSYSTEMS |
100ug |
EUR 2493.1 |
|
Description: Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable post-fusion conformation. |
Monoclonal Anti-RSV-F0 broadly Antibody, Human IgG1 (3B4) |
RSV-M649-100ug |
ACROBIOSYSTEMS |
100ug |
EUR 381.5 |
Description: Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable post-fusion conformation. |
Monoclonal Anti-RSV-F0 broadly Antibody, Human IgG1 (3B4) |
RSV-M649-1mg |
ACROBIOSYSTEMS |
1mg |
EUR 2539.7 |
Description: Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable post-fusion conformation. |
Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS41) |
NUN-S41 |
ACROBIOSYSTEMS |
100ug |
EUR 2974.6 |
|
Description: Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS41) (NUN-S41) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293). As verified by binding test with N-NTD (Cat. No. NUN-C5143) and N-CTD (Cat. No. NUN-C5145) protein, this antibody can only bind to N-CTD (AA Ser 255 - Pro 364). ELISA test validated that this antibody can bind multiple N protein variants (Cat. No. NUN-C52H8, NUN-C52Hc, NUN-C52Hd, NUN-C52Hm) with similar affinity as compared to the wild type N protein (Cat. No. NUN-C5227). |
IgG1, Human Plasma |
MBS135561-1mg |
MyBiosource |
1mg |
EUR 690 |
IgG1, Human Plasma |
MBS135561-5mg |
MyBiosource |
5mg |
EUR 1990 |
IgG1, Human Plasma |
MBS135561-5x5mg |
MyBiosource |
5x5mg |
EUR 8710 |
Mouse anti-Human IgG1 Antibody |
abx401124-05mg |
Abbexa |
0.5 mg |
EUR 794.4 |
|
Sheep anti-Human IgG1 Antibody |
abx401125-05mg |
Abbexa |
0.5 mg |
EUR 1128 |
|
Mouse Anti-Human IgG1 antibody |
STJ99560-100l |
St John's Laboratory |
100 µl |
EUR 214.8 |
Description: Unconjugated Mouse monoclonal to Human IgG1 antibody |
Mouse Anti-Human IgG1 antibody |
STJ99560-1mL |
St John's Laboratory |
1 mL |
EUR 1438.8 |
Description: Unconjugated Mouse monoclonal to Human IgG1 antibody |
Mouse Anti-Human IgG1 Antibody |
abx401124-100g |
Abbexa |
100 µg |
EUR 550 |
Anti-EGFR domain III (Nimotuzumab), Human IgG1, kappa Antibody |
A2004-200 |
Biovision |
200 µg |
EUR 612 |
Human IgG1 Anti SARS-CoV-2 Nucleoprotein Antibody (CR3009) |
MAB12434-100 |
The Native Antigen Company |
0.1 |
EUR 555.66 |
Description: This is a recombinant monoclonal antibody for the detection of SARS-CoV-2 nucleoprotein. |
Human IgG1 Anti SARS-CoV-2 Nucleoprotein Antibody (CR3018) |
MAB12437-100 |
The Native Antigen Company |
0.1 |
EUR 489.89 |
Description: Recombinant monoclonal antibody . |
Human IgG1 Anti SARS-CoV-2 Nucleoprotein Antibody (CR3018) |
MAB12437-500 |
The Native Antigen Company |
0.5 |
EUR 1865.15 |
Description: Recombinant monoclonal antibody. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (EB5) |
MAB12455-100 |
The Native Antigen Company |
0.1 |
EUR 375.07 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12440. Antibody is specific for SARS-CoV-2 spike subunit 1 protein. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (EB5) |
MAB12455-500 |
The Native Antigen Company |
0.5 |
EUR 1312.75 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12440. Antibody is specific for SARS-CoV-2 spike subunit 1 protein. |
Human IgG1 Anti SARS-CoV-2 Spike (S2) Antibody (CH1) |
MAB12462-100 |
The Native Antigen Company |
0.1 |
EUR 375.07 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12447. Antibody is specific for SARS-CoV-2 spike subunit 2 protein. |
Human IgG1 Anti SARS-CoV-2 Spike (S2) Antibody (CH1) |
MAB12462-500 |
The Native Antigen Company |
0.5 |
EUR 1312.75 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12447. Antibody is specific for SARS-CoV-2 spike subunit 2 protein. |
Monoclonal Mouse Anti-Human IgG1 |
C010215-10mg |
Unibiotest |
10mg |
EUR 2655.6 |
Monoclonal Mouse Anti-Human IgG1 |
C010215-1mg |
Unibiotest |
1mg |
EUR 525.6 |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (HH10) |
MAB12457-100 |
The Native Antigen Company |
0.1 |
EUR 375.07 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12442. Antibody is specific for SARS-CoV-2 spike subunit 1 protein. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (HH10) |
MAB12457-500 |
The Native Antigen Company |
0.5 |
EUR 1312.75 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12442. Antibody is specific for SARS-CoV-2 spike subunit 1 protein. |
Anti-Human Ephrin Type A receptor 2 (1C1), Human IgG1 Antibody |
A1095-200 |
Biovision |
each |
EUR 874.8 |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022) |
MAB12422-100 |
The Native Antigen Company |
0.1 |
EUR 489.89 |
Description: This is a recombinant monoclonal antibody. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022) |
MAB12422-500 |
The Native Antigen Company |
0.5 |
EUR 1865.15 |
Description: This is a recombinant monoclonal antibody. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022) |
MAB12453-100 |
The Native Antigen Company |
0.1 |
EUR 489.89 |
Description: This is a recombinant monoclonal antibody. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022) |
MAB12453-1000 |
The Native Antigen Company |
1.0 |
EUR 3729.02 |
Description: This is a recombinant monoclonal antibody. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022) |
MAB12453-500 |
The Native Antigen Company |
0.5 |
EUR 1865.15 |
Description: This is a recombinant monoclonal antibody. |
Human IgG1, ? Isotype Control Antibody |
A1100-200 |
Biovision |
each |
EUR 933.6 |
Breaching the Department of Defense’s Biotech Bottleneck.
The global biotechnology revolution offers a profusion of promising innovations for the US Department of Defense (DoD).
As with other emerging technologies, the commercial market, rather than defense, is driving the evolution of biotechnology products, and the ability to harness biotechnology for defense benefits has been hampered by strategic confusion in DoD. Here we describe a set of high-level challenges and a set of potential solutions that could bring innovative biotechnology closer to reality for the warfighter and DoD writ large.